The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine
出版年份 2012 全文链接
标题
The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine
作者
关键词
-
出版物
Human Vaccines & Immunotherapeutics
Volume 8, Issue 7, Pages 873-880
出版商
Informa UK Limited
发表日期
2012-06-28
DOI
10.4161/hv.20211
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines
- (2011) Jan Poolman et al. Expert Review of Vaccines
- Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults
- (2011) Nancy Bermal et al. Human vaccines & immunotherapeutics
- Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans
- (2011) Samba O. Sow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity of a Single Dose of Tetravalent Meningococcal Serogroups A, C, W-135, and Y Conjugate Vaccine Administered to 2- to 10-year-olds Is Noninferior to a Licensed-ACWY Polysaccharide Vaccine With an Acceptable Safety Profile
- (2011) Ziad A. Memish et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal ACWY Tetanus Toxoid Conjugate Vaccine in Healthy Adolescents and Young Adults 10 to 25 Years of Age
- (2011) Roger Baxter et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12–23-month-old children
- (2011) Markus Knuf et al. VACCINE
- Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles–mumps–rubella–varicella vaccine during the second year of life: An open, randomized controlled trial
- (2011) Timo Vesikari et al. VACCINE
- Safety and immunogenicity of an investigational quadrivalent meningococcal CRM197 conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America
- (2010) D. Stamboulian et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Invasive meningococcal disease and travel
- (2010) Ziad A. Memish et al. Journal of Infection and Public Health
- Quadrivalent Meningococcal Vaccination of Adults: Phase III Comparison of an Investigational Conjugate Vaccine, MenACWY-CRM, with the Licensed Vaccine, Menactra
- (2009) K. S. Reisinger et al. Clinical and Vaccine Immunology
- Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease
- (2009) Amanda C. Cohn et al. CLINICAL INFECTIOUS DISEASES
- Global epidemiology of meningococcal disease
- (2009) Lee H. Harrison et al. VACCINE
- A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children
- (2009) M. Knuf et al. VACCINE
- Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2–10 years of age
- (2009) S. Black et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now